Title Collection Author Date
3 Biotech Stock Picks Investment Trust Research & Insights Holly Black 07/07/21
Biotech Beyond Covid Investment Trust Research & Insights Holly Black 17/06/21
Big Pharma, Big Returns? Equity Research & Insights James Gard 15/03/21
Buy, Hold or Sell: International Biotechnology Trust Equity Research & Insights Annalisa Esposito 24/01/20
3 Biotech Stock Picks Fund Research & Insights Holly Black 02/10/19
Ignore Politics, Innovation is Driving Healthcare Stocks Fund Research & Insights James Gard 24/09/19
Alternative Assets Offer Opportunities Investment Trust Research & Insights Holly Black 20/06/19
How to Tap Into the Genetics Revolution Perspectives EdenTree 29/03/19
Investor Views: My Funds Have Done Better Than Stocks ISA Investing Emma Simon 07/03/19
Liontrust: 3 ESG Stock Picks Equity Research & Insights David Brenchley 23/01/19
5 Best and Worst Top-Rated Trusts in Q3 Investment Trust Research & Insights David Brenchley 04/10/18
ETF Investors Look to Healthcare Stocks ETF Research & Insights David Brenchley 13/09/18
GlaxoSmithKline Shares Still Undervalued Equity Research & Insights Damien Conover 31/07/18
Investor Views: "My Biotech Funds are Up 400%" Investment Trust Research & Insights Emma Simon 25/07/18
Woodford-Backed Prothena Loses 70% Equity Research & Insights David Brenchley 24/04/18
Will the Budget Boost Woodford's Performance? Investment Trust Research & Insights David Brenchley 01/12/17
3 Alternative Strategies for Your Portfolio Investment Trust Research & Insights Emma Wall 27/07/17
Investor Views: "I’m Sticking with Biotech Stocks – Despite 50% Falls" ISA Investing Emma Simon 21/06/17
Top 10 Investment Trusts in May Investment Trust Research & Insights Karen Kwok 12/06/17
Biotech Trusts Trade at Discount Investment Trust Research & Insights Karen Kwok 26/05/17
Are Healthcare Stocks Too Expensive? Equity Research & Insights Dan Kemp 02/05/17
Will Trump’s Policies Provide a Boost or Brake on Healthcare Funds? Fund Research & Insights Sam Shaw 07/02/17
UK Pharma Stocks Fall as Trump Repeals Obamacare Equity Research & Insights Karen Kwok 02/02/17
Pharma Stocks Remain Undervalued Despite Clinton Loss Equity Research & Insights Karen Kwok 29/11/16
Healthcare and Mining Stocks Gain On Trump Win Equity Research & Insights Karen Kwok 09/11/16
Why Healthcare Stocks Will be the Real Winner of the US Election Equity Research & Insights Karen Kwok 26/09/16
Fund Managers Attempt to Thwart EU Ban on Past Performance Data Fund Research & Insights Emma Simon 20/06/16
Star Fund Managers of the Past 10 Years Fund Research & Insights Karen Kwok 10/03/16
Top 5 Funds on Morningstar Fund Research & Insights Karen Kwok 25/02/16
5 US Stocks with a Wide Stable Moat Equity Research & Insights Karen Kwok 23/02/16
Is the Rally Over for Biotech Funds? Fund Research & Insights Karen Kwok 21/01/16
Woodford Investment Trust to Issue £80m More Shares Investment Trust Research & Insights Emma Wall 11/08/15
5 Most Popular Funds on Morningstar Fund Research & Insights Emma Wall 11/06/15
Is Glaxo's Dividend at Risk? Equity Research & Insights Damien Conover, CFA 05/02/15
Biotech Trust Up 150% in 3 Years Investment Trust Research & Insights Szymon Idzikowski 10/10/14
Healthcare benefits from defensive qualities Market Update Fernando Luque 15/04/03
Pleasant surprise in the biotech sector Market Update Fernando Luque 17/03/03
The importance of the political factor Market Update Fernando Luque 11/12/02
Gloom lifts over pharmaceutical sector Market Update Fernando Luque 07/11/02
Biotechnology under the microscope Fund Research & Insights Fernando Luque 29/08/01
Page   1 of 1
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures